Telmisartan Treatment Ameliorates Memory Deficits in Streptozotocin-Induced Diabetic Mice via Attenuating Cerebral Amyloidosis

Telmisartan, an angiotensin II type 1–receptor blocker (ARBs), has been reported to exert beneficial effects on the central nervous system (CNS). However, the effect of telmisartan on cognitive impairment associated with type 1 diabetes is not well known. Here, we examined the possibility that telmi...

Full description

Bibliographic Details

Published in:	Journal of Pharmacological Sciences
Main Authors:	Guan Tao Du, Meng Hu, Zhen Lin Mei, Chao Wang, Guang Jun Liu, Mei Hu, Yan Long, Ming Xing Miao, Jia Chang Li, Hao Hong
Format:	Article
Language:	English
Published:	Elsevier 2014-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319301641